Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors

Published:2011-06 Issue:6 Volume:46 Page:2185-2192
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Marzaro Giovanni,Chilin Adriana,Guiotto Adriano,Uriarte Eugenio,Brun Paola,Castagliuolo Ignazio,Tonus Francesca,González-Díaz Humberto

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference22 articles.

1. Issues and progress with protein kinase inhibitors for cancer treatment

2. Protein kinases — the major drug targets of the twenty-first century?

3. Chemoprevention of Breast Cancer: A Model for Change

4. Recent Advances in the Development of Multi-Kinase Inhibitors

5. From Single- to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an Advantage

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Support Vector Machine-Based Prediction Models for Drug Repurposing and Designing Novel Drugs for Colorectal Cancer;ACS Omega;2024-04-09

2. Moving Average-Based Multitasking In Silico Classification Modeling: Where Do We Stand and What Is Next?;International Journal of Molecular Sciences;2022-04-29

3. PTML Modeling for Pancreatic Cancer Research: In Silico Design of Simultaneous Multi-Protein and Multi-Cell Inhibitors;Biomedicines;2022-02-18

4. PTML modeling for peptide discovery: in silico design of non-hemolytic peptides with antihypertensive activity;Molecular Diversity;2021-11-21

5. Multi-target Drug Discovery via PTML Modeling: Applications to the Design of Virtual Dual Inhibitors of CDK4 and HER2;Current Topics in Medicinal Chemistry;2021-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3